Related Experiment Video
Updated: Apr 19, 2026
07:50
Construction of a Low-cost Mobile Incubator for Field and Laboratory Use
Published on: March 19, 2019
14.9K
Sources of drinking water in a pediatric population
Urvi G Jadav1, Bhavini S Acharya2, Gisela M Velasquez2
1Private practice, Houston, Texas, USA.
Pediatric Dentistry
|December 17, 2014
Summary
Most pediatric dental patients primarily drink bottled or vended water, not fluoridated tap water. This limits their exposure to water fluoridation, which protects against cavities.
Area of Science:
- Pediatric Dentistry
- Public Health
- Epidemiology
Background:
- Water fluoridation is a key public health measure for preventing dental caries.
- Understanding children's primary water sources is crucial for assessing fluoride intake.
- Pediatric dental practices serve a unique population whose water consumption habits may differ.
Purpose of the Study:
- To identify the main sources of drinking and cooking water used by children visiting a university pediatric dental clinic.
- To assess the prevalence of tap water consumption versus bottled or vended water among pediatric dental patients.
Main Methods:
- A seven-question survey was administered verbally to caregivers of 123 pediatric patients.
- The questionnaire was available in English and Spanish.
- Descriptive statistics and a chi-square test were used for data analysis.
Main Results:
- Only 10% of respondents used non-filtered tap water as their primary drinking source.
- Bottled water was the primary source for 52% of patients, and vended water stations for 24%.
- Non-filtered tap water was more commonly used for cooking (58%).
Conclusions:
- The majority of pediatric dental patients in this study do not consume fluoridated tap water.
- Primary reliance on bottled or vended water suggests reduced intake of beneficial fluoride.
- This pattern may compromise the caries-protective benefits of water fluoridation for these children.
More Related Videos
06:09Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine
Published on: January 12, 2024
1.1K
10:48EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. I. Collection of Virus Samples
Published on: March 28, 2015
13.0K
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
513
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513
01:29Drug Dosing: Infants and Children
935
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
935
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
392
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
392
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
895
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
373
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
01:26Pharmaceutical Poisoning: Potential Scenarios
103
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
103